HF 4373Minnesota
Changes to provisions covering prescription drug prior authorizations, transactions with group purchasers, prescription drug price transparency, health maintenance organizations, network design, coverage for immunizations, access to certain data collected, and obsolete language made.
In committee
Mar 16, 2026: Introduction and first reading, referred to Commerce Finance and Policy